Dong Dai

691 total citations
44 papers, 500 citations indexed

About

Dong Dai is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Dong Dai has authored 44 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 16 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Oncology. Recurrent topics in Dong Dai's work include Medical Imaging Techniques and Applications (12 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Radiomics and Machine Learning in Medical Imaging (8 papers). Dong Dai is often cited by papers focused on Medical Imaging Techniques and Applications (12 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Radiomics and Machine Learning in Medical Imaging (8 papers). Dong Dai collaborates with scholars based in China, United States and Hong Kong. Dong Dai's co-authors include Xiaofeng Li, Wengui Xu, Jianjing Liu, Xiuyu Song, Lei Zhu, Xikui Ma, Guotao Yin, Xiaozhou Yu, Chi K. Tse and Qi Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and Chemistry - A European Journal.

In The Last Decade

Dong Dai

43 papers receiving 492 citations

Peers

Dong Dai
Luís A. Pérez-Romasanta Spain
Arvind Rao United States
Lvhua Wang China
Prantesh Jain United States
Keisuke Tamari Japan
Junjian Liu China
Chuan Peng China
Blaise Mooney United States
Günter Schmidt United Kingdom
Luís A. Pérez-Romasanta Spain
Dong Dai
Citations per year, relative to Dong Dai Dong Dai (= 1×) peers Luís A. Pérez-Romasanta

Countries citing papers authored by Dong Dai

Since Specialization
Citations

This map shows the geographic impact of Dong Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Dai more than expected).

Fields of papers citing papers by Dong Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Dai. The network helps show where Dong Dai may publish in the future.

Co-authorship network of co-authors of Dong Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Dong Dai. A scholar is included among the top collaborators of Dong Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Dai. Dong Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xingkai, Dong Dai, Siqi Zhang, et al.. (2025). A Cyclic Peptide‐Based Radiotheranostic Agent for Urokinase‐Type Plasminogen Activator in Tumors. Chemistry - A European Journal. 31(28). e202500479–e202500479. 1 indexed citations
2.
Dai, Dong, Wenfeng Gou, Yanli Li, et al.. (2024). Novel CDK19-Targeted Radiotracers: A Potential Design Strategy to Improve the Pharmacokinetics and Tumor Uptake. Journal of Medicinal Chemistry. 67(8). 6726–6737. 3 indexed citations
3.
4.
Cui, Yunlong, Hua Li, Tao Han, et al.. (2021). Identification of Potential Biomarkers for Liver Cancer Through Gene Mutation and Clinical Characteristics. Frontiers in Oncology. 11. 733478–733478. 4 indexed citations
5.
Li, Xiaofeng, Guotao Yin, Wei Ji, et al.. (2020). <p><sup>18</sup>F-FHBG PET-CT Reporter Gene Imaging of Adoptive CIK Cell Transfer Immunotherapy for Breast Cancer in a Mouse Model</p>. OncoTargets and Therapy. Volume 13. 11659–11668. 1 indexed citations
6.
Li, Xiaofeng, Guotao Yin, Yufan Zhang, et al.. (2019). Predictive Power of a Radiomic Signature Based on 18F-FDG PET/CT Images for EGFR Mutational Status in NSCLC. Frontiers in Oncology. 9. 1062–1062. 66 indexed citations
7.
8.
Dai, Dong, et al.. (2018). Imaging Characteristics of a Bladder Wall Paraganglioma. Clinical Nuclear Medicine. 44(1). 66–67. 9 indexed citations
9.
Li, Xiaofeng, Dong Dai, Xiuyu Song, et al.. (2017). A different representation of natural T cells and natural killer cells between tumor-infiltrating and periphery lymphocytes in human hepatocellular carcinoma. Oncology Letters. 13(5). 3291–3298. 10 indexed citations
10.
Wang, Zengliang, et al.. (2017). MicroRNA-150 functions as an antioncogenic regulator in osteosarcoma. Oncology Letters. 14(2). 2483–2490. 6 indexed citations
11.
12.
Yu, Xiaozhou, Xiaofeng Li, Xiuyu Song, et al.. (2016). Advantages and disadvantages of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of unknown primary. Oncology Letters. 12(5). 3785–3792. 18 indexed citations
13.
Li, Xiaofeng, et al.. (2016). 18F-Fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma. World Journal of Gastroenterology. 22(34). 7787–7787. 8 indexed citations
14.
Dai, Dong, Xiaofeng Li, Jian Wang, et al.. (2015). Predictive efficacy of 11C‐PD153035 PET imaging for EGFR–tyrosine kinase inhibitor sensitivity in non‐small cell lung cancer patients. International Journal of Cancer. 138(4). 1003–1012. 20 indexed citations
15.
16.
Li, Xiaofeng, Dong Dai, Xiuyu Song, et al.. (2014). A meta-analysis of cytokine-induced killer cells therapy in combination with minimally invasive treatment for hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology. 38(5). 583–591. 30 indexed citations
17.
18.
Dai, Dong, et al.. (2013). Safety and efficacy of a peripheral intravenous bolus of Licartin for the treatment of advanced hepatocellular carcinoma. Experimental and Therapeutic Medicine. 6(6). 1417–1422. 4 indexed citations
19.
Wang, Qi, et al.. (2013). Primary Pericardial Osteosarcoma on FDG PET/CT. Clinical Nuclear Medicine. 38(8). e326–e328. 11 indexed citations
20.
Dai, Dong, Wengui Xu, & Qi Wang. (2009). The value of SUV of FDG-PET/Ct in differentiation of myeloma and metastasis in patients with malignant skeletal diseases of unknown origin.. Zhonghua guke zazhi. 29(12). 1127–1130. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luís A. Pérez-Romasanta Breakdown of academic impact, for papers by Arvind Rao Breakdown of academic impact, for papers by Lvhua Wang Breakdown of academic impact, for papers by Prantesh Jain Breakdown of academic impact, for papers by Keisuke Tamari Breakdown of academic impact, for papers by Junjian Liu Breakdown of academic impact, for papers by Chuan Peng Breakdown of academic impact, for papers by Blaise Mooney Breakdown of academic impact, for papers by Günter Schmidt
Rankless by CCL
2026